Setting up a collaborative European human biological monitoring study on occupational exposure to hexavalent chromium.

Biomonitoring Effect markers Electroplating Exhaled breath condensate Hexavalent chromium Multicenter study Occupational exposure Welding

Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
10 2019
Historique:
received: 11 05 2019
revised: 08 07 2019
accepted: 09 07 2019
pubmed: 23 7 2019
medline: 1 5 2020
entrez: 23 7 2019
Statut: ppublish

Résumé

The EU human biomonitoring initiative, HBM4EU, aims to co-ordinate and advance human biomonitoring (HBM) across Europe. Within its remit, the project is gathering new, policy relevant, EU-wide data on occupational exposure to relevant priority chemicals and developing new approaches for occupational biomonitoring. In this manuscript, the hexavalent chromium [Cr(VI)] study design is presented as the first example of this HBM4EU approach. This study involves eight European countries and plans to recruit 400 workers performing Cr(VI) surface treatment e.g. electroplating or stainless steel welding activities. The aim is to collect new data on current occupational exposure to Cr(VI) in Europe and to test new methods for Cr biomonitoring, specifically the analysis of Cr(VI) in exhaled breath condensate (EBC) and Cr in red blood cells (RBC) in addition to traditional urinary total Cr analyses. Furthermore, exposure data will be complemented with early biological effects data, including genetic and epigenetic effects. Personal air samples and wipe samples are collected in parallel to help informing the biomonitoring results. We present standard operational procedures (SOPs) to support the harmonized methodologies for the collection of occupational hygiene and HBM samples in different countries.

Identifiants

pubmed: 31330491
pii: S0013-9351(19)30380-9
doi: 10.1016/j.envres.2019.108583
pii:
doi:

Substances chimiques

Air Pollutants, Occupational 0
Chromium 0R0008Q3JB
chromium hexavalent ion 18540-29-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108583

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Auteurs

Tiina Santonen (T)

Finnish Institute of Occupational Health, Finland. Electronic address: tiina.santonen@ttl.fi.

Alessandro Alimonti (A)

Istituto Superiore di Sanità, Italy.

Beatrice Bocca (B)

Istituto Superiore di Sanità, Italy.

Radu Corneliu Duca (RC)

Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Kapucijnenvoer 35, 3000 Leuven, Belgium.

Karen S Galea (KS)

Centre for Human Exposure Science, Institute of Occupational Medicine, Edinburgh, EH14 4AP, UK.

Lode Godderis (L)

Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), Kapucijnenvoer 35, 3000 Leuven, Belgium; IDEWE, External Service for Prevention and Protection at Work, Heverlee, Belgium.

Thomas Göen (T)

Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.

Bruno Gomes (B)

National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School S, Universidade Nova de Lisboa, Portugal.

Ogier Hanser (O)

French National Research and Safety Institute, France.

Ivo Iavicoli (I)

University of Naples Federico II, Italy.

Beata Janasik (B)

Nofer Institute of Occupational Medicine, Poland.

Kate Jones (K)

Health & Safety Executive, Buxton, SK17 9JN, United Kingdom.

Mirja Kiilunen (M)

Finnish Institute of Occupational Health, Finland.

Holger M Koch (HM)

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-Universität Bochum, Germany.

Elizabeth Leese (E)

Health & Safety Executive, Buxton, SK17 9JN, United Kingdom.

Veruscka Leso (V)

University of Naples Federico II, Italy.

Henriqueta Louro (H)

National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School S, Universidade Nova de Lisboa, Portugal.

Sophie Ndaw (S)

French National Research and Safety Institute, France.

Simo P Porras (SP)

Finnish Institute of Occupational Health, Finland.

Alain Robert (A)

French National Research and Safety Institute, France.

Flavia Ruggieri (F)

Istituto Superiore di Sanità, Italy.

Paul T J Scheepers (PTJ)

Radboud Institute for Health Sciences, Radboudumc, Nijmegen, the Netherlands.

Maria J Silva (MJ)

National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School S, Universidade Nova de Lisboa, Portugal.

Susana Viegas (S)

Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa and CISP - Centro de Investigação m Saúde Pública, Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa, 1600-560 Lisbon, Portugal.

Wojciech Wasowicz (W)

Nofer Institute of Occupational Medicine, Poland.

Argelia Castano (A)

Instituto de Salud Carlos III. Spain.

Ovnair Sepai (O)

Public Health England, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH